HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Thibault de la Motte Rouge Selected Research
Thibault de la Motte Rouge Research Topics
Disease
6
Neoplasms (Cancer)
01/2023 - 12/2011
5
Breast Neoplasms (Breast Cancer)
01/2023 - 06/2018
2
Triple Negative Breast Neoplasms
01/2023 - 06/2018
2
Infertility (Sterility)
01/2023 - 03/2018
2
Ovarian Neoplasms (Ovarian Cancer)
01/2023 - 07/2020
1
Endometrial Neoplasms (Endometrial Cancer)
10/2023
1
Microsatellite Instability
10/2023
1
Ovarian Epithelial Carcinoma
01/2023
1
Trophoblastic Neoplasms (Trophoblastic Tumor)
01/2023
1
Neutropenia
11/2022
1
Fatigue
11/2022
1
Lymphopenia (Lymphocytopenia)
11/2022
1
Disease Progression
11/2022
1
DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
07/2020
1
Adenocarcinoma
03/2018
1
Endodermal Sinus Tumor (Endodermal Sinus Tumors)
01/2016
1
Prostatic Neoplasms (Prostate Cancer)
12/2012
1
Systemic Scleroderma (Systemic Sclerosis)
10/2012
1
Rheumatoid Arthritis
10/2012
1
Macular Degeneration (Age-Related Maculopathy)
10/2012
1
Carcinoma (Carcinomatosis)
12/2011
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2006
Drug/Important Bio-Agent (IBA)
2
Platinum
IBA
10/2023 - 07/2020
2
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2023 - 07/2020
2
Tyrosine Kinase Inhibitors
IBA
01/2023 - 10/2012
2
Fulvestrant (Faslodex)
FDA Link
11/2022 - 01/2020
2
Anastrozole (Arimidex)
FDA Link
Generic
11/2022 - 01/2020
1
dostarlimab
IBA
10/2023
1
Immune Checkpoint Inhibitors
IBA
01/2023
1
Elements
IBA
01/2023
1
Taxoids (Taxanes)
IBA
01/2023
1
Aromatase Inhibitors
IBA
11/2022
1
Letrozole (Femara)
FDA Link
Generic
11/2022
1
palbociclib
IBA
11/2022
1
exemestane (Aromasin)
FDA Link
11/2022
1
DNA (Deoxyribonucleic Acid)
IBA
11/2022
1
polyadenosine
IBA
07/2020
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
07/2020
1
olaparib
IBA
07/2020
1
Ribose (D-Ribose)
IBA
07/2020
1
Diphosphates (Pyrophosphates)
IBA
07/2020
1
Phenobarbital (Luminal)
FDA Link
06/2018
1
Contraceptive Agents (Contraceptives)
IBA
03/2018
1
Hormones (Hormone)
IBA
03/2018
1
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
01/2016
1
Diethylstilbestrol (Stilbestrol)
FDA Link
12/2012
1
Bevacizumab (Avastin)
FDA Link
10/2012
1
Ligands
IBA
10/2012
1
TOR Serine-Threonine Kinases
IBA
10/2012
1
Monoclonal Antibodies
IBA
10/2012
1
MTOR Inhibitors
IBA
10/2012
1
Rituximab (Mabthera)
FDA Link
10/2012
1
Imatinib Mesylate (Gleevec)
FDA Link
10/2012
Therapy/Procedure
6
Therapeutics
01/2023 - 03/2006
3
Drug Therapy (Chemotherapy)
01/2023 - 01/2016
2
Immunotherapy
01/2023 - 03/2006
1
Hormonal Contraception
03/2018
1
Contraindications
03/2018
1
Contraception (Birth Control)
03/2018
1
Molecular Targeted Therapy
10/2012
1
Adjuvant Chemotherapy
12/2011